Evidence map›Paper›PMID 23101448›Full record

ArticleJournal of neurosurgery2013

Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.

Elizabeth B Claus, Lisa Calvocoressi, Melissa L Bondy, Margaret Wrensch, Joseph L Wiemels, Joellen M Schildkraut

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurosurgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 10 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 10 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review.Journal of neuropathology and experimental neurology · 2025
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Elizabeth B ClausDepartment of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520, USA. elizabeth.claus@yale.edu
Lisa Calvocoressi
Melissa L Bondy
Margaret Wrensch
Joseph L Wiemels
Joellen M Schildkraut
Yale University · USBaylor College of Medicine · USDuke University · USNeurological Surgery · USUniversity of California, San Francisco · US

Funding

Training in Molecular& Genetic Epidemiology of CancerR25CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2005 to 2018
$6.5M
The Meningioma Consortium: Genome-Wide Association StudyR01CA151933 · NCI · YALE UNIVERSITY · PI CLAUS, ELIZABETH B. · 2010 to 2013
$3.7M
Meningioma: Risk Factors and Quality of LifeR01CA109468 · NCI · YALE UNIVERSITY · PI CLAUS, ELIZABETH B. · 2006 to 2010
$3.3M
Meningioma: Risk Factors and Quality of LifeR01CA109745 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIEMELS, JOSEPH LEO · 2006 to 2010
$1.9M
Training in the Molecular & Genetic Epidemiology of CancerT32CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHENG, IONA C, ZIV, ELAD · 2020 to 2024
$1.8M
Meningioma: Risk Factors and Quality of LifeR01CA109475 · NCI · DUKE UNIVERSITY · PI ILYASOVA, DORA · 2006 to 2010
$1.4M
Meningioma: Risk Factors and Quality of LifeR01CA109473 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BONDY, MELISSA L. · 2006 to 2010
$1.1M
Meningioma: Risk Factors and Quality of LifeR01CA109461 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CLAUS, ELIZABETH B. · 2006 to 2010
$1.1M
NCI NIH HHS CA108473NCI NIH HHS CA109461NCI NIH HHS CA109468NCI NIH HHS CA109475NCI NIH HHS CA109745NCI NIH HHS CA112355NCI NIH HHS R01 CA109461NCI NIH HHS R01 CA109468NCI NIH HHS R01 CA109473NCI NIH HHS R01 CA109475NCI NIH HHS R01 CA109745NCI NIH HHS R01 CA151933NCI NIH HHS R25 CA112355NCI NIH HHS T32 CA112355
6 · The paper itself

Abstract

objectThe 2-fold higher incidence of meningioma in women compared with men has long suggested a role for hormonally mediated risk factors, but specific mechanisms remain elusive.

methodsThe study included data obtained in 1127 women 29-79 years of age with intracranial meningioma diagnosed among residents of Connecticut, Massachusetts, North Carolina, the San Francisco Bay Area, and 8 Texas counties between May 1, 2006, and October 6, 2011, and data obtained in 1092 control individuals who were frequency matched for age group and geography with meningioma patients.

resultsNo association was observed for age at menarche, age at menopause, or parity and meningioma risk. Women who reported breastfeeding for at least 6 months were at reduced risk of meningioma (OR 0.78, 95% CI 0.63-0.96). A significant positive association existed between meningioma risk and increased body mass index (p < 0.01) while a significant negative association existed between meningioma risk and current smoking (p < 0.01). Among premenopausal women, current use of oral contraceptives was associated with an increased risk of meningiomas (OR 1.8, 95% CI 1.1-2.9), while current use of hormone replacement therapy among postmenopausal women was not associated with a significant elevation in risk (OR 1.1, 95% CI 0.74-1.67). There was no association between use of fertility medications and meningioma risk.

conclusionsThe authors' study confirms associations for body mass index, breastfeeding, and cigarette smoking but provides little evidence for associations of reproductive and menstrual factors with meningioma risk. The relationship between current use of exogenous hormones and meningioma remains unclear, limited by the small numbers of patients currently on oral hormone medications and a lack of hormone receptor data for meningioma tumors.

Indexed as

Body Mass IndexBreast FeedingReproductive HistoryAdultAgedAge of OnsetConnecticutContraceptives, OralEstrogen Replacement TherapyFemaleHumansMassachusettsMenarcheMeningeal NeoplasmsMeningiomaMenopauseContraceptives, Oral

Identifiers

PMID23101448
PMCPMC3756881
OpenAlexW1872439541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.